DrugPatentWatch Database Preview
Litigation Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC. (D.N.J. 2015)
DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC. (D.N.J. 2015)
| Docket | Start Trial | Date Filed | 2015-11-09 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Parties | DOW PHARMACEUTICAL SCIENCES, INC.; TOLMAR, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC | ||
| Patents | 8,288,434; 8,663,699 | ||
| Attorneys | MELISSA ANNE CHUDEREWICZ | ||
| Firms | Pepper Hamilton LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC.
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TOLMAR, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-11-05 | 1 | United States Patent Nos. 8,288,434 (“the ’434 patent”) and 8,663,699 (“the ’699 patent”) arising under….S. Patent and Trademark Office (“PTO”) issued the ’699 patent on March 4, 2014. The ’699 patent claims… THE PATENTS IN SUIT 8. The U.S. Patent and Trademark Office (“…(“PTO”) issued the ’434 patent on October 16, 2012. The ’434 patent claims, inter alia, formulations …. Dow is the assignee of the ’434 patent. A copy of the ’434 patent is attached hereto as Exhibit A. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
